Koyfin Home > Directory > Health Care > Alder Biopharma > Price / Earnings (ltm)

Alder Biopharma Price / Earnings (ltm) Chart (ALDR)

Alder Biopharma annual/quarterly Price / Earnings (ltm) from 2014 to 2015. The price-earnings ratio (P/E ratio) is the ratio for valuing a company that measures its current share price relative to its consensus EPS estimate of the next twelve months (NTM). The price-earnings ratio is also sometimes known as the price multiple or the earnings multiple.
  • Alder Biopharma Price / Earnings (ltm) for the quarter ending May 05, 2015 was 93.73 a 5.05% increase of 4.73 year over year
  • Alder Biopharma Price / Earnings (ltm) for the last 12 months ending May 05, 2015 was 93.73 a 5.05% increase of 4.73 year over year
  • Alder Biopharma Annual Price / Earnings (ltm) for 2015 was 93.73 a 3.41% increase of 3.20 from 2014
  • Alder Biopharma Annual Price / Earnings (ltm) for 2015 was 90.53 a -2.43% decrease of -2.20 from 2014
  • Alder Biopharma Annual Price / Earnings (ltm) for 2015 was 92.73 a 4.03% increase of 3.73 from 2014
Other Valuation Metrics:
  • Alder Biopharma Market Cap for the quarter ending March 03, 2018 was $862m a 33.01% increase of 284m year over year
  • Alder Biopharma Price / Book for the quarter ending March 03, 2018 was 3.09 a 34.98% increase of 1.08 year over year
  • Alder Biopharma Enterprise Value for the quarter ending March 03, 2018 was $585m a 50.86% increase of 298m year over year
View Chart On Koyfin

Quarterly ALDR Price / Earnings (ltm) Data

05/201593.73
05/201590.53
05/201592.73
05/201589.00
04/201585.00
04/201578.93
04/201575.13
04/201579.00
04/201583.67
04/201584.50

Annual ALDR Price / Earnings (ltm) Data

201593.73
201590.53
201592.73
201589.00
201585.00
201578.93
201575.13
201579.00
201583.67
201584.50